Today we have Dr. Hebbar from #CalciMedica joining us today. Dr. Hebbar has 10+ years of clinical development and product development experience in both the #pharmaceutical and diagnostics industries. Now, Privately held CalciMedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of #autoimmune disorders, organ transplant rejection, and other immune diseases. Founded in 2007 the San Diego-based company focuses on the discovery and development of CRAC channel inhibitor drugs. With the onset of the pandemic the company registered studies targeting severe COVID-19 pneumonia, a dangerous condition.
Related Posts
